MRI evolution of new MS lesions enhancing after different doses of gadolinium

Marco Rovaris; G. Mastronardo; Claudio Gasperini; F. Prandini; Tarek Yousry; Massimo Filippi

doi:10.1111/j.1600-0404.1998.tb01725.x

Abstract

1 min read

Enhancing lesions in patients with MS are heterogeneous. Those enhancing only after TD of Gd are characterized by a milder and shorter opening of the blood-brain barrier.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1998

Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium

Massimo Filippi, Maria A. Rocca, Giovanna Rizzo, Mark A. Horsfield, Marco Rovaris, L. Minicucci, Bruno Colombo, Giancarlo Comi

Article2002

Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses

Marco Rovaris, Maria Codella, Lucia Moiola, Angelo Ghezzi, Mauro Zaffaroni, Gianluigi Mancardi, Elisabetta Capello, Francesco Sardanelli, Giancarlo Comi, Massimo Filippi

Article1997

Inter-rater variability in reporting enhancing lesions present on standard and triple dose gadolinium scans of patients with multiple sclerosis

Massimo Filippi, Frederik Barkhof, S. Bressi, TA Yousry, D. H. Miller

Article1996

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS

Massimo Filippi, Tarek Yousry, A. Campi, Christoph Kandziora, Bruno Colombo, Raymond Voltz, Vittorio Martinelli, Simone Spuler, S. Bressi, Giuseppe Scotti, Gıancarlo Comı

Article1999

Correlation between MRI and Short-Term Clinical Activity in Multiple Sclerosis: Comparison between Standard- and Triple-Dose Gd-Enhanced MRI

Marco Rovaris, M. Rodegher, Giancarlo Comi, Massimo Filippi